NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY

Objective: to analyze clinical features and immunological abnormalities in juvenile-onset systemic lupus erythematosus (SLE) with neurolupus and to compare findings with the data available in the literature.Subjects and methods. The observational retrospective study included 218 patients (190 girls...

Full description

Saved in:
Bibliographic Details
Main Authors: M. I. Kaleda, I. P. Nikishina, S. I. Glukhova, N. Yu. Stepanenko
Format: Article
Language:Russian
Published: IMA PRESS LLC 2020-04-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2874
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849400923619590144
author M. I. Kaleda
I. P. Nikishina
S. I. Glukhova
N. Yu. Stepanenko
author_facet M. I. Kaleda
I. P. Nikishina
S. I. Glukhova
N. Yu. Stepanenko
author_sort M. I. Kaleda
collection DOAJ
description Objective: to analyze clinical features and immunological abnormalities in juvenile-onset systemic lupus erythematosus (SLE) with neurolupus and to compare findings with the data available in the literature.Subjects and methods. The observational retrospective study included 218 patients (190 girls and 28 boys) with juvenileonset SLE who were treated at the Pediatric Department of the V.A. Nasonova Research Institute of Rheumatology in the period from 1992 to 2017. The investigators assessed demographic parameters, the data of clinical and laboratoryinstrumental examinations, and the results of psychological, neurological and, if indicated, psychiatric examinations. The clinical and immunological features of SLE onset were comparatively analyzed in the groups of patients with and without neurolepus, followed by a comparison of the findings with the data available in the literature.Results and discussion. Forty-five (20.6%) patients with SLE and neuropsychiatric disorders were identified, of them there were 9 (20%) boys. In the neurolupus group, the mean age at onset was 13.0±2.8 years; the median disease duration at diagnosis verification was 5.0 [3.0; 11.0] months. 60% of patients were aged 10 to 15 years at diagnosis verification. Neurolupus was significantly more often detected in 46.7% of patients with acute SLE (p=0.003). Among the clinical manifestations of a nervous system lesion, serositis (p=0.003) and kidney disease (p=0.003) were diagnosed significantly more often; chronic skin changes (p=0.076) were recorded slightly more frequently, whereas arthritis (p=0.028) was detected significantly less frequently. Of the hematological disorders, leuko- and lymphopenia (p=0.087) and thrombocytopenia (p=0.077) were noted relatively more commonly. Of the immunological disorders, patients with nervous system lesion more frequently had anti-ribonucleoprotein antibodies (p=0.073) without any differences in other immunological parameters. In general, the neurolupus group showed a greater extent of multiple organ dysfunction than the other patients (the number of clinical manifestations averaged 5.6 and 3.7, respectively; p<0.0001).In all the patients, the manifestation of neurolupus was preceded by school maladaptation and emotional disturbances. There was a preponderance of central nervous system lesion (89%) in the pattern of neuropsychiatric manifestations. Fifteen (33.3%) patients had more than one manifestation of neurolupus. Among the neuropsychiatric disorders, there were headaches (28.9%), cognitive impairment (28.9%), cerebrovascular disease (35.5%), distal sensory polyneuropathy (20%), epilepsy syndrome (15.5%), anxiety disorders (11.1%), psychoses (8.9%), myelopathy (6.7%), and chorea (4.4%). In the neurolupus group, the SLEDAI scores were significantly higher (22.0±9.5) than in the non-neurolupus group (12.9±6.5; p<0.0001).Conclusion. When the patient has an acute onset, multiple organ dysfunction, psychological problems as emotional lability, proneness to conflict, and school maladaptation, he/she must undergo comprehensive examination to exclude neurolupus before the disease manifests. Identification of nervous system lesion requires urgent intensification of therapy to improve prognosis.
format Article
id doaj-art-90764cb9ce5148529d1e583017fcf086
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2020-04-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-90764cb9ce5148529d1e583017fcf0862025-08-20T03:37:53ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922020-04-0158217117710.14412/1995-4484-2020-171-1772597NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDYM. I. Kaleda0I. P. Nikishina1S. I. Glukhova2N. Yu. Stepanenko3V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyObjective: to analyze clinical features and immunological abnormalities in juvenile-onset systemic lupus erythematosus (SLE) with neurolupus and to compare findings with the data available in the literature.Subjects and methods. The observational retrospective study included 218 patients (190 girls and 28 boys) with juvenileonset SLE who were treated at the Pediatric Department of the V.A. Nasonova Research Institute of Rheumatology in the period from 1992 to 2017. The investigators assessed demographic parameters, the data of clinical and laboratoryinstrumental examinations, and the results of psychological, neurological and, if indicated, psychiatric examinations. The clinical and immunological features of SLE onset were comparatively analyzed in the groups of patients with and without neurolepus, followed by a comparison of the findings with the data available in the literature.Results and discussion. Forty-five (20.6%) patients with SLE and neuropsychiatric disorders were identified, of them there were 9 (20%) boys. In the neurolupus group, the mean age at onset was 13.0±2.8 years; the median disease duration at diagnosis verification was 5.0 [3.0; 11.0] months. 60% of patients were aged 10 to 15 years at diagnosis verification. Neurolupus was significantly more often detected in 46.7% of patients with acute SLE (p=0.003). Among the clinical manifestations of a nervous system lesion, serositis (p=0.003) and kidney disease (p=0.003) were diagnosed significantly more often; chronic skin changes (p=0.076) were recorded slightly more frequently, whereas arthritis (p=0.028) was detected significantly less frequently. Of the hematological disorders, leuko- and lymphopenia (p=0.087) and thrombocytopenia (p=0.077) were noted relatively more commonly. Of the immunological disorders, patients with nervous system lesion more frequently had anti-ribonucleoprotein antibodies (p=0.073) without any differences in other immunological parameters. In general, the neurolupus group showed a greater extent of multiple organ dysfunction than the other patients (the number of clinical manifestations averaged 5.6 and 3.7, respectively; p<0.0001).In all the patients, the manifestation of neurolupus was preceded by school maladaptation and emotional disturbances. There was a preponderance of central nervous system lesion (89%) in the pattern of neuropsychiatric manifestations. Fifteen (33.3%) patients had more than one manifestation of neurolupus. Among the neuropsychiatric disorders, there were headaches (28.9%), cognitive impairment (28.9%), cerebrovascular disease (35.5%), distal sensory polyneuropathy (20%), epilepsy syndrome (15.5%), anxiety disorders (11.1%), psychoses (8.9%), myelopathy (6.7%), and chorea (4.4%). In the neurolupus group, the SLEDAI scores were significantly higher (22.0±9.5) than in the non-neurolupus group (12.9±6.5; p<0.0001).Conclusion. When the patient has an acute onset, multiple organ dysfunction, psychological problems as emotional lability, proneness to conflict, and school maladaptation, he/she must undergo comprehensive examination to exclude neurolupus before the disease manifests. Identification of nervous system lesion requires urgent intensification of therapy to improve prognosis.https://rsp.mediar-press.net/rsp/article/view/2874juvenile-onset systemic lupus erythematosusneurolupus in childrenchildhood and adolescence
spellingShingle M. I. Kaleda
I. P. Nikishina
S. I. Glukhova
N. Yu. Stepanenko
NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY
Научно-практическая ревматология
juvenile-onset systemic lupus erythematosus
neurolupus in children
childhood and adolescence
title NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY
title_full NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY
title_fullStr NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY
title_full_unstemmed NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY
title_short NEUROPSYCHIATRIC DISORDERS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A RETROSPECTIVE STUDY
title_sort neuropsychiatric disorders in juvenile onset systemic lupus erythematosus results from a retrospective study
topic juvenile-onset systemic lupus erythematosus
neurolupus in children
childhood and adolescence
url https://rsp.mediar-press.net/rsp/article/view/2874
work_keys_str_mv AT mikaleda neuropsychiatricdisordersinjuvenileonsetsystemiclupuserythematosusresultsfromaretrospectivestudy
AT ipnikishina neuropsychiatricdisordersinjuvenileonsetsystemiclupuserythematosusresultsfromaretrospectivestudy
AT siglukhova neuropsychiatricdisordersinjuvenileonsetsystemiclupuserythematosusresultsfromaretrospectivestudy
AT nyustepanenko neuropsychiatricdisordersinjuvenileonsetsystemiclupuserythematosusresultsfromaretrospectivestudy